← All trials
NCT01714037
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2012
- Primary completion
- Nov 1, 2014
- Completion date
- Nov 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 82
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- DebiopharmLead sponsor
- University of ToulouseOverall official - principal investigator
- Universidad Autonoma de MadridOverall official - principal investigator
- INC ResearchCollaborator
- Centre Georges Francois LeclercOverall official - principal investigator
- Newcastle UniversityOverall official - principal investigator
- Universidad Autonoma de BarcelonaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.